BMS (n=18) | MSG (n=19) | p Value | |
Age | 69.43±9.95 | 67.93±9.16 | 0.62 |
Male gender | 13 (72.2%) | 9 (47.4%) | 0.11 |
Smoking history | 5 (27.8%) | 4 (21.1%) | 0.46 |
Diabetes mellitus | 6 (29.4%) | 5 (26.3%) | 0.55 |
Prior PCI | 3 (16.7%) | 2 (10.5%) | 0.47 |
Target vessel diameter | 2.96±0.16 | 2.9±0.10 | 0.17 |
% diameter stenosis | 80.42±8.41 | 82.24±10.18 | 0.54 |
Lesion length | 15.92±2.62 | 15.83±1.73 | 0.90 |
Balloon diameter | 2.36±0.29 | 2.26±0.24 | 0.25 |
Balloon length | 15.2±2.62 | 16.43±2.68 | 0.16 |
Balloon inflation pressure | 9.67±3.9 | 8.95±3.44 | 0.54 |
Use of 2.75 mm stents | 7 (36.8%) | 7 (33.3%) | 0.82 |
Use of 23 mm stents | 5 (26.3%) | 6 (28.6%) | 0.87 |
Moderate–severe tortuosity | 17 (94.4%) | 19 (100%) | 0.47 |
Moderate– severe calcification | 3 (10.5%) | 2 (9.5%) | 0.36 |
TIMI 1–2 flow | 11 (61.1%) | 14 (73.7%) | 0.32 |
Mean ± SD.
BMS, bare metal stent; MSG, microengineered stent grooves;TIMI, thrombolysis in myocardial infarction score.